Stopping Wegovy and Starting Again: What to Expect

Why stopping feels right, and what happens next

There are many reasons people pause Wegovy: side effects that haven't settled, cost pressures, a surgical procedure coming up, pregnancy planning, or simply wanting to see how they manage without it. That feeling of wanting a break, or wondering whether you still need it, is something our prescribers hear about regularly. It is a completely understandable place to reach.

What the clinical data shows, though, is that the medicine's effect does not leave a lasting change in your body's set-point. The STEP 1 trial, published in the New England Journal of Medicine, included a follow-up phase: one year after stopping semaglutide 2.4mg, participants had regained on average about two-thirds of the weight they had lost. Appetite returned, and without the hormonal signal from the medicine, most people found eating habits drifted back toward where they had been before treatment. That is not a personal failure, it reflects the biology of a chronic condition, not a lapse in willpower.

The speed of regain varies. Some people hold their lower weight for several months before creep begins; others notice hunger returning within weeks of their last dose. Your prescriber can help you think through what realistic expectations look like for your situation, particularly if you have weight-related conditions that were improving on treatment.

What restarting Wegovy actually involves

Restarting after a gap is medically feasible. Semaglutide does not accumulate in the body in a way that makes re-exposure dangerous, and there is no clinical evidence that a prior course creates lasting contraindications for a second one. The practical question is where in the dose schedule you pick back up.

UK clinical practice (and the guidance on the NHS semaglutide medicines page) supports restarting at a lower dose after a meaningful break, rather than resuming where you left off. Your gut adapted to the medicine the first time; after weeks or months away, that adaptation will have partially reversed. Beginning at a reduced dose gives your system time to readjust and lowers the risk of the nausea, vomiting or diarrhoea that can be pronounced when you jump straight to a higher maintenance dose.

The length of the gap matters too. A two-week interruption is handled differently from a six-month pause. Your prescriber will look at how long you have been off treatment, your current weight, any changes in your health since you stopped, and whether the reason for stopping has been resolved. For guidance on what the restart process looks like step by step, our page on how to start Wegovy covers the titration schedule in detail.

Managing weight between stopping and restarting

The window between doses is where many people feel most vulnerable. Appetite is back, the structure of treatment has gone, and the scale can start moving in the wrong direction before a restart has been arranged. A few things are genuinely useful here.

Protein adequacy is one. Semaglutide tends to reduce overall intake, but when appetite returns it often does so unevenly, carbohydrate cravings can feel sharper than hunger for protein-rich foods. Keeping protein intake deliberate during a gap helps protect lean mass and moderates the pace of regain. Strength-based activity serves the same function. Neither of these requires a formal programme, but small consistent habits do more than crash compensations.

If cost is part of why you paused, it is worth reading about what Wegovy costs in the UK and how that pricing breaks down, understanding what is and isn't included in different providers' headline figures can sometimes open up options that weren't apparent before. You might also find it useful to read broader context on weight regain after stopping Wegovy and practical strategies covered on our page about stopping without regaining.

When to talk to your prescriber before making any decision

Some pauses are clinician-led and planned: before surgery, for example, your anaesthetist and surgical team need to know you are on a GLP-1 medicine, and your prescriber may recommend stopping in advance. Similarly, if you are trying to conceive, pregnant, or breastfeeding, Wegovy is not recommended and a planned pause with appropriate support is the right path. These are not decisions to make unilaterally.

If you are thinking about stopping because side effects have been difficult, that conversation is worth having before you stop. Dose adjustments, timing changes, and dietary modifications during titration can all make a meaningful difference to tolerability, sometimes enough that a full pause becomes unnecessary. Our prescribers at nume review every repeat order clinically and are available for aftercare questions seven days a week, so a quick contact via our support team is often the fastest route to working through this.

If you are not currently a patient but are weighing up whether to start, pause, or resume treatment, our Wegovy overview covers the full picture, and more context on the broader question of what stopping actually means is covered in a related piece. When you are ready to take the next step, you can check your eligibility through a free consultation with a GPhC-registered prescriber.